2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Translation of the document prepared by the Czech Society of Cardiology

被引：1

作者：

Taborsky, Milos ^{[1
,2
]}

Kautzner, Josef ^{[3
]}

Fedorco, Marian ^{[1
,2
]}

Curila, Karol ^{[4
,5
]}

Wunschova, Hanka

Pyszko, Jan ^{[1
,2
]}

Novak, Miroslav ^{[6
,7
]}

Kozak, Milan ^{[8
,9
]}

Valek, Martin ^{[10
,11
]}

Polasek, Rostislav ^{[12
]}

Keprt, Patrik

Kubickova, Milena ^{[13
,14
,15
]}

Plasek, Jiri ^{[16
,17
]}

Gloger, Vit ^{[18
]}

Bulava, Alan ^{[19
,20
]}

Vancura, Vlastimil ^{[21
,22
]}

Skala, Tomas ^{[1
,2
]}

Parizek, Petr ^{[23
,24
]}

Danek, Josef ^{[25
,26
]}

机构：

[1] Univ Palackeho Olomouci, Lekarska Fak, Interni Klin Kardiol 1, IP Pavlova 6, Olomouc 77900, Czech Republic

[2] Fak Nemocnice Olomouc, IP Pavlova 6, Olomouc 77900, Czech Republic

[3] Inst Klin Expt Med, Klin Kardiol, Prague, Czech Republic

[4] Univ Karlovy, Lekarska Fak 3, Kardiol Klin, Prague, Czech Republic

[5] Fak Nemocnice Kralovske Vinohrady, Prague, Czech Republic

[6] Masarykovy Univ, Lekarska Fak, Interni Kardioangiol Klin 1, Brno, Czech Republic

[7] Fak Nemocnice Sv Anny Brne, Brno, Czech Republic

[8] Masarykovy Univ, Lekarska Fak, Interni Kardiol Klin, Brno, Czech Republic

[9] Fak Nemocnice Brno, Brno, Czech Republic

[10] Univ Karlovy, Lekarska Fak 1, Interni Klin Kardiol & Angiol, Prague, Czech Republic

[11] Vseobecna Fak Nemocnice Praze, Prague, Czech Republic

[12] Krajska Nemocnice Liberec As, Kardiovask Ctr, Liberec, Czech Republic

[13] Univ JE Purkyne Usti Nad Labem, Fak Zdravotnickych, Kardiol Klin, Usti Nad Labem, Czech Republic

[14] Krajska Zdravotni As, Usti Nad Labem, Czech Republic

[15] Masarykova Nemocnice Usti Nad Labem, Oz, Usti Nad Labem, Czech Republic

[16] Ostravske Univ, Lekarska Fak, Interni Kardiol Klin, Ostrava, Czech Republic

[17] Fak Nemocnice Ostrava, Ostrava, Czech Republic

[18] Krajska Nemocnice Tomase Bati Zline, Kardiol Oddeleni, Zlin, Czech Republic

[19] Nemocnice Ceske Budejovice As, Kardiol Oddeleni, Ceske Budejovice, Czech Republic

[20] Jihoceske Univ Ceskych Budejovicich, Zdravotne Socialni Fak, Ceske Budejovice, Czech Republic

[21] Univ Karlova, Lekarska Fak Plzen, Kardiol Klin, Plzen, Czech Republic

[22] Fak Nemocnice Plzen, Plzen, Czech Republic

[23] Univ Karlovy, Lekarska Fak, Interni Kardioangiol Klin 1, L, Hradec Kralove, Czech Republic

[24] Fak Nemocnice Hradec Kralove, Hradec Kralove, Czech Republic

[25] Univ Karlovy, Lekarska Fak 1, Interni Klin, Kardiol Oddeleni, Prague, Czech Republic

[26] Ustredni Vojenska Nemocnice, Prague, Czech Republic

来源：

COR ET VASA | 2023年 / 65卷

关键词：

apixaban; dabigatran; DOACs; edoxaban; NOACs; rivaroxaban;

D O I：

10.33678/cor.2023.024

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：23 / 75

页数：53

共 50 条

[41] The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis
Yang, Kuang-Tsu
Sun, Wei-Chih
Tsai, Tzung-Jiun
Tsay, Feng-Woei
Chen, Wen-Chi
Cheng, Jin-Shiung
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (01) : 1 - 16
[42] The association of non-vitamin K antagonist oral anticoagulants vs. warfarin and the risk of fractures for patients with atrial fibrillation: a systematic review and meta-analysis
Yang, Nana
Zhao, Ying
Bai, Zhaohui
Chen, Haokun
Ning, Haoyu
Zou, Meijuan
Cheng, Gang
ACTA CARDIOLOGICA, 2023, 78 (03) : 298 - 310
[43] Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease
Lee, Hsin-Fu
See, Lai-Chu
Li, Pei-Ru
Liu, Jia-Rou
Chao, Tze-Fan
Chang, Shang-Hung
Wu, Lung-Sheng
Yeh, Yung-Hsin
Kuo, Chi-Tai
Chan, Yi-Hsin
Lip, Gregory Y. H.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (01) : 50 - 58
[44] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation and valvular heart disease
Li, Hsing-Jung
Lin, Shin-Yi
Lin, Fang-Ju
Hung, Chi-Sheng
Wang, Chi-Chuan
CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 535 - 542
[45] Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with advanced chronic kidney and liver diseases
Liao, Jo-Nan
Kuo, Ling
Liu, Chih-Min
Chen, Shih-Ann
Chao, Tze-Fan
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : A11 - A18
[46] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation
Kim, Hyue Mee
Choi, Eue-Keun
Park, Chan Soon
Cha, Myung-Jin
Lee, Seo-Young
Kwon, Joon-Myung
Oh, Seil
PLOS ONE, 2019, 14 (03):
[47] Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation
Lee, So-Ryoung
Lee, Young Soo
Park, Ji-Suck
Cha, Myung-Jin
Kim, Tae-Hoon
Park, Junbeom
Park, Jin-Kyu
Lee, Jung-Myung
Kang, Ki-Woon
Shim, Jaemin
Uhm, Jae-Sun
Kim, Jun
Kim, Changsoo
Kim, Jin-Bae
Park, Hyung Wook
Joung, Boyoung
Choi, Eue-Keun
YONSEI MEDICAL JOURNAL, 2019, 60 (03) : 277 - 284
[48] Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data
Xue, Zhengbiao
Zhou, Yue
Wu, Chaoyu
Lin, Jie
Liu, Xin
Zhu, Wengen
HEART FAILURE REVIEWS, 2020, 25 (06) : 957 - 964
[49] Use of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Malignancy: Clinical Practice Experience in a Single Institution and Literature Review
Russo, Vincenzo
Rago, Anna
Papa, Andrea Antonio
Di Meo, Federica
Attena, Emilio
Golino, Paolo
D'Onofrio, Antonio
Nigro, Gerardo
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2018, 44 (04) : 370 - 376
[50] Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants
Raparelli, Valeria
Proietti, Marco
Cangemi, Roberto
Lip, Gregory Y. H.
Lane, Deirdre A.
Basili, Stefania
THROMBOSIS AND HAEMOSTASIS, 2017, 117 (02) : 209 - 218

← 1 2 3 4 5 →